Drugs / CD34+ Cells
last change Mar 2017 re-read 2 minutes ago

CD34+ Cells

Cell therapy

Developed for
non-Hodgkin lymphoma
Investigated by
Stanford University

Trials 1 · a red edge is where a trial was stopped

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00481832 Jan 2007 → Oct 2014 non-Hodgkin lymphoma Stanford University Terminated No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as CD34+ Cells ClinicalTrials.gov intervention name — accepted as the source's own label NCT00481832
Modality Cell therapy “stem cell transplant using the patient's own cells” NCT00481832